dRx Capital
Europe, Basel-Stadt, Switzerland, Basel
Description
Novartis Digital Health Venture Capital
Investor Profile
dRx Capital has made 32 investments, with 0 in the past 12 months and 13% as lead.
Stage Focus
- Series B (31%)
- Series C (28%)
- Series A (22%)
- Seed (6%)
- Post Ipo Equity (6%)
- Pre Seed (3%)
- Series D (3%)
Country Focus
- United States (91%)
- United Kingdom (6%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Germany (3%)
Industry Focus
- Health Care
- Biotechnology
- Therapeutics
- Medical
- Analytics
- Software
- Life Science
- Clinical Trials
- Home Health Care
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
